- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.08. | Motus GI Holdings, Inc. - 15-12G, Securities registration termination | 4 | SEC Filings | ||
| 31.07. | Motus GI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| MOTUS GI Aktie jetzt für 0€ handeln | |||||
| 21.05. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.05.2024 | 2.521 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 21.05.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.05.2024.ISIN NameCA00379L1067 ABRASILV.... ► Artikel lesen | |
| 18.03. | Motus GI Holdings, Inc.: Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | 233 | GlobeNewswire (Europe) | Initiated limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system, including successful UGI procedures at several leading hospital systemsThe Company is engaged in the process... ► Artikel lesen | |
| 21.02. | Motus GI Holdings, Inc.: Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu System to Avoid Clogging in Cleansing the GI Tract | 234 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. ("the "Company") (NASDAQ: MOTS), a medical technology company focused on improving endoscopic outcomes and experiences... ► Artikel lesen | |
| 30.01. | Motus GI Holdings, Inc.: Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation | 192 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or "Motus GI" or "the Company"), a medical technology company focused on improving endoscopic outcomes... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 77,82 | +0,32 % | DuraStat partners with Medtronic on surgical tissue closure tech | ||
| INTUITIVE SURGICAL | 509,80 | -1,94 % | $100 Invested In Intuitive Surgical 5 Years Ago Would Be Worth This Much Today | ||
| ROKU | 76,09 | -4,28 % | Roku launches new QLED TV models with CHiQ in the UK | Available in 43" and 50" screen sizes, the new 4K QLED TV models are for sale on Amazon
LONDON, Dec. 13, 2024 /PRNewswire/ -- Roku, Inc., a pioneer in TV streaming, and CHiQ, a leading... ► Artikel lesen | |
| SERNOVA | 0,141 | -7,12 % | Sernova Aktie: Fortschritte bei Cell Pouch System | Die kanadische Biotechnologiefirma Sernova verzeichnet bedeutende Entwicklungen bei ihrer innovativen Cell Pouch Technologie. Das Unternehmen, das sich auf regenerative Medizinlösungen für chronische... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,975 | -1,22 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density | 1 MG Dose (Z)-Endoxifen Shows Potential as a Well-Tolerated, Preventative Therapy for Premenopausal Women at Risk of Developing Breast Cancer Data to be Presented in a Poster Spotlight Session During... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,520 | -100,00 % | SNOA-Aktie erreicht 52-Wochen-Tief bei 2,44 US-Dollar | ||
| CYTOSORBENTS | 0,830 | +6,41 % | Insider Buying: Cytosorbents Co. (NASDAQ:CTSO) CFO Buys 11,363 Shares of Stock | ||
| QUIDELORTHO | 41,600 | +0,97 % | QuidelOrtho Reports Third Quarter 2024 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,698 | -9,18 % | TPST-Aktie erreicht 52-Wochen-Tief bei 0,8 US-Dollar | ||
| CENTENE | 57,12 | +3,65 % | Centene Backs Annual Earnings Outlook Above View, Initiates 2025 Guidance | WASHINGTON (dpa-AFX) - Centene Corporation (CNC), a healthcare enterprise, on Thursday reaffirmed its annual guidance for 2024 and initiated outlook for the full year 2025.For the full year... ► Artikel lesen | |
| ONTRAK | 1,550 | 0,00 % | OTRK-Aktie erreicht 52-Wochen-Tief bei 1,58 US-Dollar | ||
| VERU | 0,659 | -2,73 % | Veru Inc reports results for the quarter ended September 30 - Earnings Summary | ||
| PATTERSON COMPANIES | 29,600 | 0,00 % | XFRA PD2: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPATTERSON COS INC.... ► Artikel lesen | |
| FULGENT GENETICS | 18,400 | -1,08 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen |
MOTUS GI HOLDINGS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,429 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOTUS GI HOLDINGS INC finden Sie auf Wallstreet Online.
